The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The initial development, branded ‘Traza’, is designed to guarantee safety and traceability throughout the chemotherapy process, from prescription to administration of the drug, including aseptic preparation in the pharmacy lab. This solution has since been successfully deployed in many hospitals and pharmacies having delivered over 1Million Cancer Drug Doses with ZERO ERRORS, thereby proven to guarantee patient safety.
Later solutions include intelligent developments for automation and control of drug distribution, using the ‘mobile’ for HDMA, home delivery of patient medications, and a unique intelligent robotic solution for hospital pharmacy Unit Dose distribution.
The company’s ethos is to use automation and innovative design to answer the call to eliminate medication errors and improve efficiencies in drug management and distribution. Using advanced computing and leading automation methodologies to deliver day-to-day improvements in efficiencies, safety and security, enhance patient outcomes, lower costs, and provide audited data ‘visualised’ to aid accurate reporting for daily ‘decision making’. All solutions ensure an intuitive user experience for rapid deployment with minimal impact on staff and existing processes.
The company maintains a development base in Madrid and has expanded its offices to cover the Spanish speak territories, Europe and now North America having opened an office in Boston, last year.